NO331483B1 - Preparat som inneholder konjugert linolsyre, naeringsmiddelprodukt og dyrefôr omfattende preparatet, og anvendelse av preparatet - Google Patents
Preparat som inneholder konjugert linolsyre, naeringsmiddelprodukt og dyrefôr omfattende preparatet, og anvendelse av preparatet Download PDFInfo
- Publication number
- NO331483B1 NO331483B1 NO20004615A NO20004615A NO331483B1 NO 331483 B1 NO331483 B1 NO 331483B1 NO 20004615 A NO20004615 A NO 20004615A NO 20004615 A NO20004615 A NO 20004615A NO 331483 B1 NO331483 B1 NO 331483B1
- Authority
- NO
- Norway
- Prior art keywords
- cla
- isomers
- linoleic acid
- acid
- reaction
- Prior art date
Links
- 229940108924 conjugated linoleic acid Drugs 0.000 title claims abstract description 143
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 title claims abstract description 41
- 241001465754 Metazoa Species 0.000 title claims description 29
- 235000013305 food Nutrition 0.000 title claims description 20
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 title claims 5
- 239000000203 mixture Substances 0.000 title abstract description 76
- 238000002360 preparation method Methods 0.000 claims description 27
- 235000019485 Safflower oil Nutrition 0.000 claims description 20
- 239000003813 safflower oil Substances 0.000 claims description 20
- 235000005713 safflower oil Nutrition 0.000 claims description 20
- 235000021588 free fatty acids Nutrition 0.000 claims description 19
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 17
- 150000003626 triacylglycerols Chemical class 0.000 claims description 14
- ADHNUPOJJCKWRT-JLXBFWJWSA-N (2e,4e)-octadeca-2,4-dienoic acid Chemical class CCCCCCCCCCCCC\C=C\C=C\C(O)=O ADHNUPOJJCKWRT-JLXBFWJWSA-N 0.000 claims description 9
- 235000019486 Sunflower oil Nutrition 0.000 claims description 8
- 239000002600 sunflower oil Substances 0.000 claims description 8
- 125000005907 alkyl ester group Chemical group 0.000 claims description 7
- 239000013589 supplement Substances 0.000 claims description 5
- 235000006486 human diet Nutrition 0.000 claims description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract description 31
- 235000020778 linoleic acid Nutrition 0.000 abstract description 26
- 239000000047 product Substances 0.000 abstract description 24
- 235000015872 dietary supplement Nutrition 0.000 abstract description 5
- 235000019730 animal feed additive Nutrition 0.000 abstract 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 58
- 238000006243 chemical reaction Methods 0.000 description 52
- 238000000034 method Methods 0.000 description 43
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 33
- 238000006317 isomerization reaction Methods 0.000 description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 239000003513 alkali Substances 0.000 description 27
- 239000003921 oil Substances 0.000 description 27
- 235000019198 oils Nutrition 0.000 description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 150000002148 esters Chemical class 0.000 description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 235000014113 dietary fatty acids Nutrition 0.000 description 19
- 239000000194 fatty acid Substances 0.000 description 19
- 229930195729 fatty acid Natural products 0.000 description 19
- 150000004665 fatty acids Chemical class 0.000 description 18
- 230000021615 conjugation Effects 0.000 description 17
- 230000008569 process Effects 0.000 description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 241000030538 Thecla Species 0.000 description 14
- 235000019441 ethanol Nutrition 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 235000005911 diet Nutrition 0.000 description 11
- JBYXPOFIGCOSSB-XBLVEGMJSA-N 9E,11E-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C\CCCCCCCC(O)=O JBYXPOFIGCOSSB-XBLVEGMJSA-N 0.000 description 10
- 239000003054 catalyst Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 9
- 230000037213 diet Effects 0.000 description 8
- 238000005886 esterification reaction Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000035484 reaction time Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- 230000032050 esterification Effects 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 108090001060 Lipase Proteins 0.000 description 6
- 239000004367 Lipase Substances 0.000 description 6
- 102000004882 Lipase Human genes 0.000 description 6
- 241000282887 Suidae Species 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 238000004817 gas chromatography Methods 0.000 description 6
- 235000019421 lipase Nutrition 0.000 description 6
- 150000002632 lipids Chemical group 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 244000020518 Carthamus tinctorius Species 0.000 description 5
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 241000282849 Ruminantia Species 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000003125 aqueous solvent Substances 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 229960004106 citric acid Drugs 0.000 description 5
- JGFMXQLVWUGIPI-UHFFFAOYSA-N octadeca-11,13-dienoic acid Chemical compound CCCCC=CC=CCCCCCCCCCC(O)=O JGFMXQLVWUGIPI-UHFFFAOYSA-N 0.000 description 5
- QJKCKUNKNNYJNS-UHFFFAOYSA-N octadeca-8,10-dienoic acid Chemical compound CCCCCCCC=CC=CCCCCCCC(O)=O QJKCKUNKNNYJNS-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 241001661345 Moesziomyces antarcticus Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 229930182558 Sterol Natural products 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 150000003432 sterols Chemical class 0.000 description 4
- 235000003702 sterols Nutrition 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 3
- -1 1-octadecanoic acid ester Chemical class 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- ADHNUPOJJCKWRT-UHFFFAOYSA-N octadeca-2,4-dienoic acid Chemical compound CCCCCCCCCCCCCC=CC=CC(O)=O ADHNUPOJJCKWRT-UHFFFAOYSA-N 0.000 description 3
- 230000020477 pH reduction Effects 0.000 description 3
- 125000001095 phosphatidyl group Chemical group 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000004767 rumen Anatomy 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 3
- GKJZMAHZJGSBKD-UHFFFAOYSA-N (10E,12E)-Octadeca-9,11-dienoic acid Natural products CCCCCC=CC=CCCCCCCCCC(O)=O GKJZMAHZJGSBKD-UHFFFAOYSA-N 0.000 description 2
- GKJZMAHZJGSBKD-BLHCBFLLSA-N (10e,12e)-octadeca-10,12-dienoic acid Chemical compound CCCCC\C=C\C=C\CCCCCCCCC(O)=O GKJZMAHZJGSBKD-BLHCBFLLSA-N 0.000 description 2
- GKJZMAHZJGSBKD-ANYPYVPJSA-N 10-trans-12-cis-linoleic acid Natural products CCCCCC=C\C=C\CCCCCCCCC(O)=O GKJZMAHZJGSBKD-ANYPYVPJSA-N 0.000 description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 2
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 208000016444 Benign adult familial myoclonic epilepsy Diseases 0.000 description 2
- 101150065749 Churc1 gene Proteins 0.000 description 2
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 102100038239 Protein Churchill Human genes 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000011260 aqueous acid Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229960002303 citric acid monohydrate Drugs 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- OANFWJQPUHQWDL-UHFFFAOYSA-N copper iron manganese nickel Chemical compound [Mn].[Fe].[Ni].[Cu] OANFWJQPUHQWDL-UHFFFAOYSA-N 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 208000016427 familial adult myoclonic epilepsy Diseases 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000006140 methanolysis reaction Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000000199 molecular distillation Methods 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000021485 packed food Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940073455 tetraethylammonium hydroxide Drugs 0.000 description 2
- LRGJRHZIDJQFCL-UHFFFAOYSA-M tetraethylazanium;hydroxide Chemical compound [OH-].CC[N+](CC)(CC)CC LRGJRHZIDJQFCL-UHFFFAOYSA-M 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- GKJZMAHZJGSBKD-NMMTYZSQSA-N (10E,12Z)-octadecadienoic acid Chemical compound CCCCC\C=C/C=C/CCCCCCCCC(O)=O GKJZMAHZJGSBKD-NMMTYZSQSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 102100027324 2-hydroxyacyl-CoA lyase 1 Human genes 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000605902 Butyrivibrio Species 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 101001009252 Homo sapiens 2-hydroxyacyl-CoA lyase 1 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 101100514842 Xenopus laevis mtus1 gene Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 238000000998 batch distillation Methods 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000003043 biohydrogenation Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000015223 cooked beef Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000000669 high-field nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000000207 lymphocyte subset Anatomy 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002759 monoacylglycerols Chemical class 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- PJSQIDIRJGWHOB-UHFFFAOYSA-N octadeca-4,6-dienoic acid Chemical compound CCCCCCCCCCCC=CC=CCCC(O)=O PJSQIDIRJGWHOB-UHFFFAOYSA-N 0.000 description 1
- CNKMVAJDUBKHMS-UHFFFAOYSA-N octadeca-6,8-dienoic acid Chemical compound CCCCCCCCCC=CC=CCCCCC(O)=O CNKMVAJDUBKHMS-UHFFFAOYSA-N 0.000 description 1
- HACBQSMIIGXKGA-UHFFFAOYSA-N octadeca-7,9-dienoic acid Chemical compound CCCCCCCCC=CC=CCCCCCC(O)=O HACBQSMIIGXKGA-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-GTFORLLLSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCC[14C](O)=O QIQXTHQIDYTFRH-GTFORLLLSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000002328 sterol group Chemical group 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Fodder In General (AREA)
- Fats And Perfumes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4253898A | 1998-03-17 | 1998-03-17 | |
US09/042,767 US6015833A (en) | 1998-03-17 | 1998-03-17 | Conjugated linoleic acid compositions |
US09/132,593 US7078051B1 (en) | 1998-08-11 | 1998-08-11 | Conjugated linoleic acid alkyl esters in feedstuffs and food |
US16041698A | 1998-09-25 | 1998-09-25 | |
PCT/US1999/005806 WO1999047135A1 (fr) | 1998-03-17 | 1999-03-17 | Compositions a base d'acides linoleiques conjugues |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20004615D0 NO20004615D0 (no) | 2000-09-15 |
NO20004615L NO20004615L (no) | 2000-11-07 |
NO331483B1 true NO331483B1 (no) | 2012-01-16 |
Family
ID=27488800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20004615A NO331483B1 (no) | 1998-03-17 | 2000-09-15 | Preparat som inneholder konjugert linolsyre, naeringsmiddelprodukt og dyrefôr omfattende preparatet, og anvendelse av preparatet |
Country Status (14)
Country | Link |
---|---|
US (4) | US6410761B1 (fr) |
EP (1) | EP0950410B1 (fr) |
JP (1) | JP2000516480A (fr) |
KR (1) | KR100619651B1 (fr) |
AT (1) | ATE350028T1 (fr) |
AU (1) | AU764699B2 (fr) |
CA (1) | CA2289648C (fr) |
DE (1) | DE69934627T2 (fr) |
DK (1) | DK0950410T3 (fr) |
ES (1) | ES2279586T3 (fr) |
IN (1) | IN2000KO00319A (fr) |
MX (1) | MX238954B (fr) |
NO (1) | NO331483B1 (fr) |
WO (1) | WO1999047135A1 (fr) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776353B1 (en) | 1998-03-17 | 2010-08-17 | Aker Biomarine Asa | Conjugated linoleic acid compositions |
US7078051B1 (en) | 1998-08-11 | 2006-07-18 | Natural Asa | Conjugated linoleic acid alkyl esters in feedstuffs and food |
US6410761B1 (en) | 1998-03-17 | 2002-06-25 | Conlinco, Inc. | Conjugated linoleic acid compositions and methods of making same |
US7101914B2 (en) | 1998-05-04 | 2006-09-05 | Natural Asa | Isomer enriched conjugated linoleic acid compositions |
FR2784268B1 (fr) * | 1998-10-12 | 2000-12-29 | Gervais Danone Sa | Nouvelle composition alimentaire, a base de matiere issue du lait, sous la forme d'une emulsion huile dans eau |
GB2355382A (en) * | 1999-08-24 | 2001-04-25 | Gilbertson & Page Ltd | Conjugated linoleic acid for weight reduction in a dog |
JP4262382B2 (ja) * | 2000-02-03 | 2009-05-13 | 株式会社ヤクルト本社 | 共役脂肪酸グリセリド含有発酵食品及びその製造法 |
AU2001251449B2 (en) * | 2000-04-06 | 2005-04-07 | Conlinco, Inc. | Conjugated linoleic acid compositions |
US6756405B2 (en) | 2000-04-18 | 2004-06-29 | Natural Asa | Conjugated linoleic acid powder |
US20030149288A1 (en) * | 2000-04-18 | 2003-08-07 | Natural Asa | Conjugated linoleic acid powder |
US6380409B1 (en) * | 2000-04-24 | 2002-04-30 | Conlin Co., Inc. | Methods for preparing CLA isomers |
DE10046402B4 (de) * | 2000-09-18 | 2006-04-20 | Cognis Ip Management Gmbh | Verfahren zur Herstellung von Rohstoffen für die Gewinnung von konjugierter Linolsäure |
AU2001252569B2 (en) * | 2001-04-25 | 2008-06-19 | Kabushiki Kaisha Yakult Honsha | Fermented foods and process for producing the same |
DE10143534B4 (de) | 2001-09-06 | 2005-03-24 | Cognis Deutschland Gmbh & Co. Kg | Verfahren zur Herstellung von konjugierten Fettsäureestern |
US6677470B2 (en) | 2001-11-20 | 2004-01-13 | Natural Asa | Functional acylglycerides |
AU2003205279B2 (en) * | 2002-01-22 | 2007-08-23 | Mars, Incorporated | Weight management system for obese animals |
US20030138547A1 (en) * | 2002-01-22 | 2003-07-24 | Mars, Incorporated | Weight management system for animals |
DE10208812A1 (de) * | 2002-03-01 | 2003-09-11 | Basf Plant Science Gmbh | Verfahren zur Herstellung von ungesättigten Fettsäuren |
DE10236086A1 (de) * | 2002-08-07 | 2004-02-19 | Cognis Deutschland Gmbh & Co. Kg | Verfahren zur Herstellung von konjugierter Linolsäure |
US7244874B2 (en) * | 2002-09-17 | 2007-07-17 | The Regents Of The University Of California | Stearoyl CoA desaturase transgenic non-human animals |
US6743931B2 (en) | 2002-09-24 | 2004-06-01 | Natural Asa | Conjugated linoleic acid compositions |
AU2003293020A1 (en) * | 2002-11-26 | 2004-06-18 | George Washington University | Method and composition with conjugated linoleic acid esters |
DE10259157A1 (de) * | 2002-12-18 | 2004-07-01 | Cognis Deutschland Gmbh & Co. Kg | Verfahren zur Herstellung von konjugierter Linolsäure |
US6897327B2 (en) * | 2003-05-08 | 2005-05-24 | Stepan Company | Manufacture of conjugated linoleic salts and acids |
WO2005026091A1 (fr) * | 2003-09-09 | 2005-03-24 | Kao Corporation | Procede de production d'alcool |
US20050069593A1 (en) * | 2003-09-29 | 2005-03-31 | Life Time Fitness, Inc. | Nutritional supplement containing 7-Keto-DHEA and conjugated linoleic acid |
US20070191619A1 (en) * | 2003-12-23 | 2007-08-16 | Stepan Company | Production and purification of esters of conjugated linoleic acids |
EP1729851A2 (fr) | 2004-03-10 | 2006-12-13 | Natural ASA | Compositions comportant des isomeres inverses d'acide linoleique conjugue |
DE102004015782A1 (de) * | 2004-03-31 | 2005-10-20 | Cognis Ip Man Gmbh | Verfahren zur enzymatischen Synthese von Triglyceriden ungesättigter Fettsäuren |
DE102004015781A1 (de) * | 2004-03-31 | 2005-10-20 | Cognis Ip Man Gmbh | Verfahren zur enzymatischen Synthese von Triglyceriden ungesättigter Fettsäuren |
JP4772295B2 (ja) * | 2004-06-22 | 2011-09-14 | 学校法人順天堂 | 共役脂肪酸を有効成分とする運動能力改善剤 |
US7767713B2 (en) * | 2004-08-05 | 2010-08-03 | Palo Alto Investors | Linoleic acid active agents for enhancing probability of becoming pregnant |
DE102004043824A1 (de) | 2004-09-10 | 2006-03-16 | Cognis Ip Management Gmbh | Emulsionen mit ungesättigten Fettsäuren und deren Estern |
KR101189886B1 (ko) * | 2004-10-08 | 2012-10-10 | 닛신 오일리오그룹 가부시키가이샤 | 불포화지방산 농축물의 제조방법 |
ES2395254T3 (es) * | 2005-02-04 | 2013-02-11 | Lipid Nutrition B.V. | Procedimiento para la preparación de ácidos grasos |
ES2296438B1 (es) * | 2005-03-04 | 2009-03-16 | Corporacion Alimentaria Peñasanta, S.A. | Alimento funcional a base de un producto lacteo no fermentado y acido linoleico conjugado. |
CA2609341C (fr) * | 2005-05-23 | 2011-10-04 | Natural Asa | Concentration d'esters alkyliques d'acides gras produite par des reactions enzymatiques avec du glycerol |
US20070049763A1 (en) * | 2005-08-23 | 2007-03-01 | Reaney Martin J | Methods for preparation and use of strong base catalysts |
US20070087085A1 (en) * | 2005-10-17 | 2007-04-19 | Bunge Oils, Inc. | Protein-containing food product and coating for a food product and method of making same |
US20080113067A1 (en) * | 2005-10-17 | 2008-05-15 | Monoj Sarma | Protein-Containing Food Product and Coating for a Food Product and Method of Making Same |
ATE478836T1 (de) * | 2005-12-05 | 2010-09-15 | Stepan Co | Verfahren zur herstellung von konjugierter linolsäure und derivaten davon aus ricinolsäure |
US20070148311A1 (en) * | 2005-12-22 | 2007-06-28 | Bunge Oils, Inc. | Phytosterol esterification product and method of make same |
US20070218183A1 (en) * | 2006-03-14 | 2007-09-20 | Bunge Oils, Inc. | Oil composition of conjugated linoleic acid |
DE102007009650A1 (de) | 2007-02-26 | 2008-08-28 | Beiersdorf Ag | Kosmetisches Kombinationsprodukt zur Verbesserung des äußeren Erscheinungsbildes |
DE102007009649A1 (de) | 2007-02-26 | 2008-08-28 | Beiersdorf Ag | Nahrungsergänzungsmittel zur Pflege und/oder Verschönerung der Haut |
ES2748136T3 (es) | 2007-10-15 | 2020-03-13 | United Animal Health Inc | Método para aumentar el rendimiento de las crías |
EP2391370B1 (fr) | 2009-02-02 | 2015-06-03 | Galmed Research and Development Ltd. | Procédés et compositions de traitement de la maladie d'alzheimer |
CA2818480A1 (fr) | 2010-11-25 | 2012-05-31 | Katholieke Universiteit Leuven | Procede pour la production d'acides gras polyinsatures conjugues avec des catalyseurs heterogenes |
CN102640805B (zh) * | 2011-02-18 | 2014-12-10 | 丰宁京北第一草原原生态食品科技开发有限公司 | 食用植物油脂脱臭、脱酸、去除苯并芘的方法 |
EP2508894A1 (fr) * | 2011-04-05 | 2012-10-10 | Receptomon LLC | Procédé de surveillance de l'expression de gènes de translation et synthèse de protéines intégrales/sécrétion par spectroscopie à résonance magnétique (MRS) |
US20130136827A1 (en) * | 2011-11-28 | 2013-05-30 | James S. Drouillard | Method and Composition for Increasing The Proportion of Dietary Ingredients That Are Resistant To Degradation by Ruminal Microorganisms |
US10154979B2 (en) | 2013-03-11 | 2018-12-18 | Sciadonics, Inc. | Lipid compositions containing bioactive fatty acids |
EP2826384A1 (fr) | 2013-07-16 | 2015-01-21 | Evonik Industries AG | Procédé destiné au séchage de biomasse |
CN103849660B (zh) * | 2014-03-28 | 2016-01-06 | 大连医诺生物有限公司 | 一种以固定化脂肪酶为催化剂的耦联法制备共轭亚油酸的方法 |
BR112017005388B1 (pt) | 2014-10-02 | 2022-09-13 | Evonik Operations Gmbh | Alimento para animais contendo biomassa de aurantiochytrium |
BR112017006833B1 (pt) | 2014-10-02 | 2022-09-13 | Evonik Operations Gmbh | Alimento para animais contendo ácido graxo poli-insaturado e processo para produzir o mesmo |
WO2016050552A1 (fr) | 2014-10-02 | 2016-04-07 | Evonik Degussa Gmbh | Procédé de production d'une biomasse contenant des agpi qui présente une haute stabilité cellulaire |
ES2873094T3 (es) | 2014-10-02 | 2021-11-03 | Evonik Operations Gmbh | Procedimiento para la producción de un pienso que contiene PUFAs mediante extrusión de una biomasa que contiene PUFAs de tipo Labyrinthulomycetes |
US9752099B2 (en) | 2014-12-05 | 2017-09-05 | Board Of Trustees Of The University Of Arkansas | Conjugated linoleic acid rich vegetable oil production using heterogeneous catalysis |
US20200033360A1 (en) * | 2017-03-31 | 2020-01-30 | Metabolon, Inc. | Comprehensive and quantitative lipid and tocopherol analysis |
US20230348951A1 (en) | 2022-04-28 | 2023-11-02 | Société des Produits Nestlé S.A. | Diagnosing and treating chronic kidney disease in a feline |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2242230A (en) | 1941-05-20 | Process of producing conjugation in | ||
GB558881A (fr) | 1900-01-01 | |||
US2350583A (en) | 1944-06-06 | Drying oils | ||
US3050619A (en) * | 1959-10-02 | 1962-08-21 | Raylite Electric Corp | Display outfits with separable decorative floral cover constructions |
DE1156788C2 (de) | 1959-12-02 | 1973-11-22 | Brinckmann Harburger Fett | Verfahren zur Umwandlung von Fettsaeureestern einwertiger Alkohole mit isolierten Doppelbindungen (íÀIsolenfettsaeureesterníÂ) in Fettsaeureester mit konjugierten Doppelbindungen (íÀKonjuenfettsaeureesteríÂ) |
US3278567A (en) | 1965-01-19 | 1966-10-11 | Pacific Vegets Le Oil Corp | Process for conjugating and isomerizing drying oils and products |
US3433939A (en) * | 1965-10-22 | 1969-03-18 | Kenneth A Sieloff | Decorative night light |
US3610917A (en) * | 1968-05-22 | 1971-10-05 | John D Hunt | Lighting fixture |
US3711696A (en) * | 1970-10-22 | 1973-01-16 | K Sieloff | Floral decorative night light |
US3729379A (en) * | 1971-08-31 | 1973-04-24 | Us Agriculture | Hydroxy-conjugated fatty acids |
US4164505A (en) | 1977-07-08 | 1979-08-14 | Sylvachem Corporation | Flow process for conjugating unconjugated unsaturation of fatty acids |
US4215462A (en) * | 1978-12-04 | 1980-08-05 | Fernandez Emile C | Method of making a translucent optical diffuser for a lamp |
DE3019963A1 (de) | 1980-05-24 | 1981-12-03 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur konjugierung mehrfach ungesaettigter fettsaeuren und fettsaeuregemische |
US5017614A (en) | 1989-02-17 | 1991-05-21 | Wisconsin Alumni Research Foundation | Methods of preventing oxidation, quenching singlet oxygen and inhibiting mold growth and novel compositions therefor |
US5070104A (en) | 1989-02-17 | 1991-12-03 | Wisconsin Alumni Research Foundation | Methods of chelating metal and novel compositions therefor |
US5208356A (en) * | 1989-02-17 | 1993-05-04 | Wisconsin Alumni Research Foundation | Octadecadienoic phospholipic esters, antioxidant and mold inhibiting compositions |
US5288619A (en) | 1989-12-18 | 1994-02-22 | Kraft General Foods, Inc. | Enzymatic method for preparing transesterified oils |
DE69122717T2 (de) | 1990-05-14 | 1997-05-07 | Eastman Kodak Co | Fotografische filme enthaltend silberhalogenidkörner mit geringen zwillingsebenenabständen |
US5468887A (en) * | 1992-03-13 | 1995-11-21 | The Dial Corp. | Production of fatty acid methyl esters and soaps therefrom |
US5674901A (en) | 1995-06-01 | 1997-10-07 | Wisconsin Alumni Research Foundation | Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations |
US5428072A (en) * | 1992-04-29 | 1995-06-27 | Wisconsin Alumni Research Foundation | Method of increasing the efficiency of feed conversion in animals |
US5430066A (en) | 1992-04-29 | 1995-07-04 | Wisconsin Alumni Research Foundation | Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation |
US5554646A (en) | 1992-04-29 | 1996-09-10 | Wisconsin Alumni Research Foundation | Method for reducing body fat in animals |
US5760082C1 (en) | 1994-08-29 | 2001-03-06 | Wisconsin Alumni Res Found | Dietetic foods containing conjugated linoleic acids |
US5814663A (en) * | 1994-08-29 | 1998-09-29 | Wisconsin Alumni Research Foundation | Method for maintaining an existing level of body fat |
MY118354A (en) | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
US5856149A (en) | 1995-06-01 | 1999-01-05 | Wisconsin Alumni Research Foundation | Method of producing conjugated fatty acids |
DE69609196T3 (de) | 1995-11-14 | 2006-01-26 | Loders Croklaan B.V. | Verfahren zur Herstellung von Materialien mit hohem Gehalt an isomeren von konjugierter Linolsäure |
EP0779033B1 (fr) | 1995-11-14 | 2001-09-26 | Unilever N.V. | Produit à tartiner comestible |
US5585400A (en) | 1996-02-27 | 1996-12-17 | Wisconsin Alumni Research Foundation | Methods of attenuating the allergic response in animals |
JP2000509079A (ja) | 1996-04-11 | 2000-07-18 | ロダース・クロックラーン・ビー・ブイ | 自由流動性脂肪組成物 |
AUPO028696A0 (en) | 1996-06-06 | 1996-07-04 | Van Gelder-Stubbeng Pty Limited | A waste mill |
US5725873A (en) | 1996-07-22 | 1998-03-10 | Wisconsin Alumni Research Foundation | Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
US5804210A (en) | 1996-08-07 | 1998-09-08 | Wisconsin Alumni Research Foundation | Methods of treating animals to maintain or enhance bone mineral content and compositions for use therein |
US5760083A (en) | 1996-08-07 | 1998-06-02 | Wisconsin Alumni Research Foundation | Use of CLA to reduce the incidence of valgus and varus leg deforomities in poultry |
JP3017108B2 (ja) * | 1996-10-30 | 2000-03-06 | リノール油脂株式会社 | 共役リノール酸の製造方法 |
US5855917A (en) | 1996-12-04 | 1999-01-05 | Wisconsin Alumni Research Foundation | Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids |
US5850305A (en) | 1996-12-18 | 1998-12-15 | Scientific-Atlanta, Inc. | Adaptive predistortion control for optical external modulation |
US5885594A (en) * | 1997-03-27 | 1999-03-23 | The Procter & Gamble Company | Oral compositions having enhanced mouth-feel |
US5851572A (en) | 1997-04-25 | 1998-12-22 | Wisconsin Alumni Research Foundation | Method of increasing fat firmness and improving meat quality in animals with conjugated linolenic acid |
DE19718245C5 (de) | 1997-04-30 | 2004-11-11 | Cognis Deutschland Gmbh & Co. Kg | Synthetische Triglyceride auf Basis konjugierter Linolsäure, Verfahren zu deren Herstellung und deren Verwendung |
CA2246085C (fr) | 1997-09-12 | 2004-04-27 | Krish Bhaggan | Production de matieres riches en isomeres conjugues de residus d'acides gras a longue chaine polyinsaturee |
US6015833A (en) | 1998-03-17 | 2000-01-18 | Conlinco., Inc. | Conjugated linoleic acid compositions |
US6410761B1 (en) | 1998-03-17 | 2002-06-25 | Conlinco, Inc. | Conjugated linoleic acid compositions and methods of making same |
CA2287252A1 (fr) * | 1999-10-22 | 2001-04-22 | Kuo Fen Shu | Porte-ampoule a diode electroluminescente ameliore pour jeu de lumieres de noel de type del |
US6364501B1 (en) * | 1999-12-02 | 2002-04-02 | Hung-Te Tai | Illuminative vase-type scented ornamental decoration structure |
GB9929897D0 (en) | 1999-12-18 | 2000-02-09 | Slabas Antoni R | Improvements in or relating to conjugated fatty acids and related compounds |
EP2295594B1 (fr) | 2000-01-19 | 2018-04-04 | DSM IP Assets B.V. | Procedé d'extraction sans solvant |
US20030043579A1 (en) * | 2001-08-31 | 2003-03-06 | Rong Zhu Jian | Decorative lighting string |
-
1999
- 1999-03-17 US US09/270,940 patent/US6410761B1/en not_active Expired - Lifetime
- 1999-03-17 DE DE69934627T patent/DE69934627T2/de not_active Expired - Lifetime
- 1999-03-17 AU AU31886/99A patent/AU764699B2/en not_active Ceased
- 1999-03-17 DK DK99105497T patent/DK0950410T3/da active
- 1999-03-17 CA CA002289648A patent/CA2289648C/fr not_active Expired - Fee Related
- 1999-03-17 EP EP99105497A patent/EP0950410B1/fr not_active Revoked
- 1999-03-17 US US09/271,024 patent/US7029691B1/en not_active Expired - Lifetime
- 1999-03-17 JP JP11547251A patent/JP2000516480A/ja not_active Withdrawn
- 1999-03-17 WO PCT/US1999/005806 patent/WO1999047135A1/fr active IP Right Grant
- 1999-03-17 AT AT99105497T patent/ATE350028T1/de not_active IP Right Cessation
- 1999-03-17 ES ES99105497T patent/ES2279586T3/es not_active Expired - Lifetime
- 1999-03-17 KR KR1020007010266A patent/KR100619651B1/ko not_active IP Right Cessation
-
2000
- 2000-09-15 NO NO20004615A patent/NO331483B1/no not_active IP Right Cessation
- 2000-09-15 IN IN319KO2000 patent/IN2000KO00319A/en unknown
- 2000-09-15 MX MXPA00009106 patent/MX238954B/es active IP Right Grant
-
2002
- 2002-04-18 US US10/124,972 patent/US6610868B2/en not_active Expired - Lifetime
-
2003
- 2003-07-21 US US10/623,825 patent/US7514096B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO20004615L (no) | 2000-11-07 |
MXPA00009106A (es) | 2002-04-01 |
DE69934627T2 (de) | 2007-10-25 |
DK0950410T3 (da) | 2007-05-07 |
MX238954B (es) | 2006-07-26 |
EP0950410A1 (fr) | 1999-10-20 |
US20020169332A1 (en) | 2002-11-14 |
WO1999047135A8 (fr) | 2001-07-05 |
IN2000KO00319A (fr) | 2005-03-11 |
AU764699B2 (en) | 2003-08-28 |
US20040018225A1 (en) | 2004-01-29 |
US7514096B2 (en) | 2009-04-07 |
ATE350028T1 (de) | 2007-01-15 |
ES2279586T3 (es) | 2007-08-16 |
DE69934627D1 (de) | 2007-02-15 |
AU3188699A (en) | 1999-10-11 |
US6410761B1 (en) | 2002-06-25 |
CA2289648A1 (fr) | 1999-09-23 |
KR100619651B1 (ko) | 2006-09-05 |
WO1999047135A1 (fr) | 1999-09-23 |
NO20004615D0 (no) | 2000-09-15 |
CA2289648C (fr) | 2004-06-01 |
US6610868B2 (en) | 2003-08-26 |
JP2000516480A (ja) | 2000-12-12 |
KR20010074447A (ko) | 2001-08-04 |
EP0950410B1 (fr) | 2007-01-03 |
US7029691B1 (en) | 2006-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO331483B1 (no) | Preparat som inneholder konjugert linolsyre, naeringsmiddelprodukt og dyrefôr omfattende preparatet, og anvendelse av preparatet | |
US6015833A (en) | Conjugated linoleic acid compositions | |
US6891054B2 (en) | Functional acylglycerides | |
NO333298B1 (no) | Konjugerte linolsyreblandinger | |
JP2010195825A (ja) | 異性体濃縮共役リノール酸組成物の使用方法 | |
EP1276709B1 (fr) | Procedes de preparation d'isomeres d'acide linoleique conjugue (alc) | |
NO332556B1 (no) | Fremgangsmate for a tilveiebringe et stabilisert, konjugert linolsyreprodukt | |
NO325536B1 (no) | Blanding omfattende et pulver inneholdende konjugert linolsyre, fremgangsmate for fremstilling og anvendelse derav. | |
AU2001257627A1 (en) | Methods for preparing CLA isomers | |
AU2001251449A1 (en) | Conjugated linoleic acid compositions | |
AU2001255431A1 (en) | Conjugated linoleic acid powder | |
JP2015129136A (ja) | 共役リノール酸組成物 | |
NO330190B1 (no) | Fremgangsmate for fremstilling av et pulver som omfatter en olje omfattende konjugert linolsyre og en eksipiens. | |
US7776353B1 (en) | Conjugated linoleic acid compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |